Naoki Mori

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 13

Top Topics

Histone Deacetylase

Acute Myeloid Leukemia

Plasmodium Falciparum

Top Venues

European journal of haematology

Medical oncology (Northwood, London, England)

Investigational new drugs

This page only lists publications with an associated author ORCID identifier.

Publications

Chie Ishikawa, Naoki Mori
Pivotal role of dihydroorotate dehydrogenase as a therapeutic target in adult T-cell leukemia. European journal of haematology 113 (1) (2024)
Chie Ishikawa, Naoki Mori
A New Strategy for Adult T-Cell Leukemia Treatment Targeting Glycogen Synthase Kinase-3β. European journal of haematology (2024)
Chie Ishikawa, Naoki Mori
Pivotal role of dihydroorotate dehydrogenase as a therapeutic target in adult T-cell leukemia. European journal of haematology (2024)
Chie Ishikawa, Naoki Mori
Pivotal role of dihydroorotate dehydrogenase as a therapeutic target in adult T-cell leukemia. European journal of haematology 113 (1) (2024)
Chie Ishikawa, Naoki Mori
Heat shock factor 1 is a promising therapeutic target against adult T-cell leukemia. Medical oncology (Northwood, London, England) 40 (6) (2023)
Chie Ishikawa, Naoki Mori
Heat shock factor 1 is a promising therapeutic target against adult T-cell leukemia. Medical oncology (Northwood, London, England) 40 (6) (2023)
Chie Ishikawa, Naoki Mori
Heat shock factor 1 is a promising therapeutic target against adult T-cell leukemia. Medical oncology (Northwood, London, England) 40 (6) (2023)
Chie Ishikawa, Naoki Mori
FX1, a BCL6 inhibitor, reactivates BCL6 target genes and suppresses HTLV-1-infected T cells. Investigational new drugs (2021)
Chie Ishikawa, Naoki Mori
The role of CUDC-907, a dual phosphoinositide-3 kinase and histone deacetylase inhibitor, in inhibiting proliferation of adult T-cell leukemia. European journal of haematology 105 (6) (2020)
Chie Ishikawa, Naoki Mori
The anti-malaria agent artesunate exhibits cytotoxic effects in primary effusion lymphoma. Investigational new drugs 39 (1) (2020)
Chie Ishikawa, Masachika Senba, Naoki Mori
Importin β1 regulates cell growth and survival during adult T cell leukemia/lymphoma therapy. Investigational new drugs 39 (2) (2020)
Chie Ishikawa, Naoki Mori
MALT-1 as a novel therapeutic target for adult T-cell leukemia. European journal of haematology 105 (4) (2020)
Chie Ishikawa, Masachika Senba, Tadashi Hashimoto, Atsushi Imaizumi, Naoki Mori
Expression and significance of Pim-3 kinase in adult T-cell leukemia. European journal of haematology 99 (6) (2017)